HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV

Bibliographic Details
Main Author: Alencar, Cecilia Salete [UNIFESP]
Publication Date: 2013
Other Authors: Sabino, Ester Cerdeira [UNIFESP], Carvalho, Silvia M. F., Leao, Silvana C., Carneiro-Proietti, Anna B., Capuani, Ligia, Oliveira, Claudia L., Carrick, Danielle, Birch, Rebecca J., Goncalez, Thelma T., Keating, Sheila, Swanson, Priscilla A., Hackett, John, Busch, Michael P., NHLBI Retrovirus Epidemiology, Int Component
Format: Article
Language: eng
Source: Repositório Institucional da UNIFESP
Download full: http://doi.org/10.1097/QAI.0b013e31828ff979
http://repositorio.unifesp.br/handle/11600/44147
Summary: Background: There are few surveillance studies analyzing genotypes or primary (transmitted) drug resistance in HIV-infected blood donors in Brazil. The aim of this study was to characterize patterns of HIV genotypes and primary resistance among HIV-seropositive donors identified at 4 geographically dispersed blood centers in Brazil.Methods: All HIV-infected donors who returned for counseling at the 4 REDS-II Hemocenters in Brazil from January 2007 to March 2011 were invited to participate in a case-control study involving a questionnaire on risk factors. Viral sequencing was also offered to positive cases to assign genotypes and to detect and characterize primary resistance to reverse transcriptase and protease inhibitors according to World Health Organization guidelines.Results: Of the 341 HIV-seropositive donors who consented to participate in the risk factor and genetics study, pol sequences were obtained for 331 (97%). Clade B was predominant (76%) followed by F (15%) and C (5%). Primary resistance was present in 36 [12.2%, 95% confidence interval (CI) 8.2 to 15.5] of the 303 individuals not exposed to antiretroviral therapy, varying from 8.2% (95% CI: 2.7 to 13.6) in Recife to 19.4% in Sao Paulo (95% CI: 9.5 to 29.2); there were no significant correlations with other demographics or risk factors.Conclusions: Although subtype B remains the most prevalent genotype in all 4 areas, increasing rates of subtype C in Sao Paulo and F in Recife were documented relative to earlier reports. Transmitted drug resistance was relatively frequent, particularly in the city of Sao Paulo which showed an increase compared with previous HIV-seropositive donor data from 10 years ago.
id UFSP_a99233be2b3eefed6e09b174adacadfe
oai_identifier_str oai:repositorio.unifesp.br/:11600/44147
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIVHIVgenotypesblood donorsBrazilBackground: There are few surveillance studies analyzing genotypes or primary (transmitted) drug resistance in HIV-infected blood donors in Brazil. The aim of this study was to characterize patterns of HIV genotypes and primary resistance among HIV-seropositive donors identified at 4 geographically dispersed blood centers in Brazil.Methods: All HIV-infected donors who returned for counseling at the 4 REDS-II Hemocenters in Brazil from January 2007 to March 2011 were invited to participate in a case-control study involving a questionnaire on risk factors. Viral sequencing was also offered to positive cases to assign genotypes and to detect and characterize primary resistance to reverse transcriptase and protease inhibitors according to World Health Organization guidelines.Results: Of the 341 HIV-seropositive donors who consented to participate in the risk factor and genetics study, pol sequences were obtained for 331 (97%). Clade B was predominant (76%) followed by F (15%) and C (5%). Primary resistance was present in 36 [12.2%, 95% confidence interval (CI) 8.2 to 15.5] of the 303 individuals not exposed to antiretroviral therapy, varying from 8.2% (95% CI: 2.7 to 13.6) in Recife to 19.4% in Sao Paulo (95% CI: 9.5 to 29.2); there were no significant correlations with other demographics or risk factors.Conclusions: Although subtype B remains the most prevalent genotype in all 4 areas, increasing rates of subtype C in Sao Paulo and F in Recife were documented relative to earlier reports. Transmitted drug resistance was relatively frequent, particularly in the city of Sao Paulo which showed an increase compared with previous HIV-seropositive donor data from 10 years ago.Univ Fed Sao Paulo, Dept Infect Dis, Sao Paulo, BrazilHosp Clin FMUSP, LIM03, Lab Med Lab, Dept Patol, Sao Paulo, BrazilUniv Sao Paulo, Dept Infect Dis, Inst Trop Med, BR-05403000 Sao Paulo, BrazilHemorio, Rio De Janeiro, BrazilHemope, Recife, PE, BrazilHemominas, Belo Horizonte, MG, BrazilFundacao Prosangue, Hemoctr Sao Paulo, Sao Paulo, BrazilFed Univ Sao Joao del Rey, Divinopolis, BrazilWestat Corp, Rockville, MD USABlood Syst Res Inst, San Francisco, CA USAAbbott Diagnost, Emerging Pathogens & Virus Discovery, Abbott Pk, IL USAUniv Fed Sao Paulo, Dept Infect Dis, Sao Paulo, BrazilWeb of ScienceNIIHNIIH: HHSN268200417175C/HO/NHLBI NIH HHSLippincott Williams & WilkinsUniversidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)HemorioHemopeHemominasFundacao ProsangueFed Univ Sao Joao del ReyWestat CorpBlood Syst Res InstAbbott DiagnostAlencar, Cecilia Salete [UNIFESP]Sabino, Ester Cerdeira [UNIFESP]Carvalho, Silvia M. F.Leao, Silvana C.Carneiro-Proietti, Anna B.Capuani, LigiaOliveira, Claudia L.Carrick, DanielleBirch, Rebecca J.Goncalez, Thelma T.Keating, SheilaSwanson, Priscilla A.Hackett, JohnBusch, Michael P.NHLBI Retrovirus EpidemiologyInt Component2018-06-15T17:49:53Z2018-06-15T17:49:53Z2013-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion387-392http://doi.org/10.1097/QAI.0b013e31828ff979Jaids-journal Of Acquired Immune Deficiency Syndromes. Philadelphia: Lippincott Williams & Wilkins, v. 63, n. 3, p. 387-392, 2013.10.1097/QAI.0b013e31828ff9791525-4135http://repositorio.unifesp.br/handle/11600/44147WOS:000330448700028engJaids-journal Of Acquired Immune Deficiency Syndromesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-05-02T15:58:46Zoai:repositorio.unifesp.br/:11600/44147Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-05-02T15:58:46Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
title HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
spellingShingle HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
Alencar, Cecilia Salete [UNIFESP]
HIV
genotypes
blood donors
Brazil
title_short HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
title_full HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
title_fullStr HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
title_full_unstemmed HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
title_sort HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV
author Alencar, Cecilia Salete [UNIFESP]
author_facet Alencar, Cecilia Salete [UNIFESP]
Sabino, Ester Cerdeira [UNIFESP]
Carvalho, Silvia M. F.
Leao, Silvana C.
Carneiro-Proietti, Anna B.
Capuani, Ligia
Oliveira, Claudia L.
Carrick, Danielle
Birch, Rebecca J.
Goncalez, Thelma T.
Keating, Sheila
Swanson, Priscilla A.
Hackett, John
Busch, Michael P.
NHLBI Retrovirus Epidemiology
Int Component
author_role author
author2 Sabino, Ester Cerdeira [UNIFESP]
Carvalho, Silvia M. F.
Leao, Silvana C.
Carneiro-Proietti, Anna B.
Capuani, Ligia
Oliveira, Claudia L.
Carrick, Danielle
Birch, Rebecca J.
Goncalez, Thelma T.
Keating, Sheila
Swanson, Priscilla A.
Hackett, John
Busch, Michael P.
NHLBI Retrovirus Epidemiology
Int Component
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Hemorio
Hemope
Hemominas
Fundacao Prosangue
Fed Univ Sao Joao del Rey
Westat Corp
Blood Syst Res Inst
Abbott Diagnost
dc.contributor.author.fl_str_mv Alencar, Cecilia Salete [UNIFESP]
Sabino, Ester Cerdeira [UNIFESP]
Carvalho, Silvia M. F.
Leao, Silvana C.
Carneiro-Proietti, Anna B.
Capuani, Ligia
Oliveira, Claudia L.
Carrick, Danielle
Birch, Rebecca J.
Goncalez, Thelma T.
Keating, Sheila
Swanson, Priscilla A.
Hackett, John
Busch, Michael P.
NHLBI Retrovirus Epidemiology
Int Component
dc.subject.por.fl_str_mv HIV
genotypes
blood donors
Brazil
topic HIV
genotypes
blood donors
Brazil
description Background: There are few surveillance studies analyzing genotypes or primary (transmitted) drug resistance in HIV-infected blood donors in Brazil. The aim of this study was to characterize patterns of HIV genotypes and primary resistance among HIV-seropositive donors identified at 4 geographically dispersed blood centers in Brazil.Methods: All HIV-infected donors who returned for counseling at the 4 REDS-II Hemocenters in Brazil from January 2007 to March 2011 were invited to participate in a case-control study involving a questionnaire on risk factors. Viral sequencing was also offered to positive cases to assign genotypes and to detect and characterize primary resistance to reverse transcriptase and protease inhibitors according to World Health Organization guidelines.Results: Of the 341 HIV-seropositive donors who consented to participate in the risk factor and genetics study, pol sequences were obtained for 331 (97%). Clade B was predominant (76%) followed by F (15%) and C (5%). Primary resistance was present in 36 [12.2%, 95% confidence interval (CI) 8.2 to 15.5] of the 303 individuals not exposed to antiretroviral therapy, varying from 8.2% (95% CI: 2.7 to 13.6) in Recife to 19.4% in Sao Paulo (95% CI: 9.5 to 29.2); there were no significant correlations with other demographics or risk factors.Conclusions: Although subtype B remains the most prevalent genotype in all 4 areas, increasing rates of subtype C in Sao Paulo and F in Recife were documented relative to earlier reports. Transmitted drug resistance was relatively frequent, particularly in the city of Sao Paulo which showed an increase compared with previous HIV-seropositive donor data from 10 years ago.
publishDate 2013
dc.date.none.fl_str_mv 2013-07-01
2018-06-15T17:49:53Z
2018-06-15T17:49:53Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://doi.org/10.1097/QAI.0b013e31828ff979
Jaids-journal Of Acquired Immune Deficiency Syndromes. Philadelphia: Lippincott Williams & Wilkins, v. 63, n. 3, p. 387-392, 2013.
10.1097/QAI.0b013e31828ff979
1525-4135
http://repositorio.unifesp.br/handle/11600/44147
WOS:000330448700028
url http://doi.org/10.1097/QAI.0b013e31828ff979
http://repositorio.unifesp.br/handle/11600/44147
identifier_str_mv Jaids-journal Of Acquired Immune Deficiency Syndromes. Philadelphia: Lippincott Williams & Wilkins, v. 63, n. 3, p. 387-392, 2013.
10.1097/QAI.0b013e31828ff979
1525-4135
WOS:000330448700028
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Jaids-journal Of Acquired Immune Deficiency Syndromes
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 387-392
dc.publisher.none.fl_str_mv Lippincott Williams & Wilkins
publisher.none.fl_str_mv Lippincott Williams & Wilkins
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1841453733051891712